APA (7th ed.) Citation

Bauer, R., Enns, H., Jungmann, A., Volz, H. C., Schinkel, S., Raake, P., . . . Müller, O. J. (2019). Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) mice. Neuromuscular disorders, 29(3), . https://doi.org/10.1016/j.nmd.2018.12.006

Chicago Style (17th ed.) Citation

Bauer, Ralf, Helene Enns, Andreas Jungmann, Hans Christian Volz, Stefanie Schinkel, Philip Raake, Patrick Most, Hugo Katus, and Oliver J. Müller. "Various Effects of AAV9-mediated βARKct Gene Therapy on the Heart in Dystrophin-deficient (mdx) Mice and δ-sarcoglycan-deficient (Sgcd-/-) Mice." Neuromuscular Disorders 29, no. 3 (2019). https://doi.org/10.1016/j.nmd.2018.12.006.

MLA (9th ed.) Citation

Bauer, Ralf, et al. "Various Effects of AAV9-mediated βARKct Gene Therapy on the Heart in Dystrophin-deficient (mdx) Mice and δ-sarcoglycan-deficient (Sgcd-/-) Mice." Neuromuscular Disorders, vol. 29, no. 3, 2019, https://doi.org/10.1016/j.nmd.2018.12.006.